Clinical Trial Update: Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial investigating elamipretide to improve left ventricular function in adults with heart failure with reduced ejection fraction has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2020-04-22